Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

NCT03296033 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
122
Enrollment
OTHER
Sponsor class

Stopped enrollment proved to be a challenge due to the changing of the guidelines for bridging off the new anticoagulants that are being prescribed

Conditions

Interventions

Sponsor

Wake Forest University Health Sciences